Velocity tracings of the healthy controls in our cohort.) حسب Inmaculada Villanueva-Baxarias (21454246)

الموضوعات:

Individual characteristics of the participants. حسب Surakshya Khanal (19949745)

الموضوعات:

Physiological regions considering ventricular depth variations. حسب Inmaculada Villanueva-Baxarias (21454246)

الموضوعات:

Factors associated with practice regarding osteoporosis among the study participants. حسب Surakshya Khanal (19949745)

الموضوعات:

Comparison of the computational model’s healthy baseline simulated traces (black) with those obtained by ultrasound from control cases (grey), after manually tuning the model’s par... حسب Inmaculada Villanueva-Baxarias (21454246)

الموضوعات:

Factors associated with knowledge regarding osteoporosis among the study participants. حسب Surakshya Khanal (19949745)

الموضوعات:

Confirmed aortic coarctation case at 32 weeks of gestation. حسب Inmaculada Villanueva-Baxarias (21454246)

الموضوعات:

Attitude regarding osteoporosis among the study participants. حسب Surakshya Khanal (19949745)

الموضوعات:

Confidence intervals for physiological regions. حسب Inmaculada Villanueva-Baxarias (21454246)

الموضوعات:

Knowledge regarding osteoporosis among the study participants. حسب Surakshya Khanal (19949745)

الموضوعات:

Changes in relative abundance of genera in both therapeutic groups. حسب Flavia Furlaneto (20161022)

"…<p>Box plots represent the 3 genera that differed significantly between groups in terms of changes in abundance. …"

Flowchart of the study. حسب Flavia Furlaneto (20161022)

"…At species level, <i>Schaalia</i> spp., <i>Streptococcus gordonii</i>, and <i>Leptotrichia wadei</i> increased in Placebo and decreased in the Probiotic group after treatment. <i>Granulicatella adiacens</i> decreased significantly after the probiotic therapy, while <i>Saccharibacteria</i> (TM7) spp., <i>Solobacterium moorei</i>, and <i>Catonella morbi</i> increased significantly. …"

Shares of antibiotic substances on total prescription in UTI treatment (N39.0, N30.0) by sex and age group in 2019 (female: n = 238.670 prescriptions; male: n = 40.641 prescription... حسب Thomas Hanslmeier (19949694)

الموضوعات: "…fluoroquinolone shares decreased…"

Shares of antibiotic substances on total prescription by quarter from 2013 to 2019 for female and male patients with UTI (N39.0, N30.0)(female: n = 1.681.255 prescriptions; male: n... حسب Thomas Hanslmeier (19949694)

الموضوعات: "…fluoroquinolone shares decreased…"

Shares of specialist groups prescribing 1^st, 2^nd, and 3^rd antibiotic prescriptions in UTI treatment of females (N39.0, N30.0) in 2018 and 2019. حسب Thomas Hanslmeier (19949694)

الموضوعات: "…fluoroquinolone shares decreased…"

Number of antibiotic prescriptions in female and male patients with UTI (N30.0 and/or N39.0). حسب Thomas Hanslmeier (19949694)

الموضوعات: "…fluoroquinolone shares decreased…"

Shares of antibiotic substances on total prescription in female patients with UTI (N39.0, N30.0) by physician specialties (GPs: n = 1.299.641 prescriptions; gynecologists n = 141.8... حسب Thomas Hanslmeier (19949694)

الموضوعات: "…fluoroquinolone shares decreased…"

Comparison of 1^st, 2^nd, and 3^rd antibiotic prescription. حسب Thomas Hanslmeier (19949694)

الموضوعات: "…fluoroquinolone shares decreased…"

UTI diagnoses by sex and physician specialty (2013–2019). حسب Thomas Hanslmeier (19949694)

الموضوعات: "…fluoroquinolone shares decreased…"

Proposed work plan; 1) Blood and 24-hour urine tests including oxalate and citrate analysis, 2) Metabolomics analysis out of blood and urine samples. حسب Haris Omić (21175546)

الموضوعات: